Quarterly report pursuant to Section 13 or 15(d)

ACQUISITIONS (Details Narrative)

v3.21.2
ACQUISITIONS (Details Narrative)
$ in Millions
1 Months Ended 6 Months Ended
Dec. 31, 2019
USD ($)
Aug. 31, 2019
USD ($)
shares
Dec. 31, 2018
USD ($)
ft²
shares
Jun. 30, 2021
ft²
Oct. 31, 2019
ft²
Dec. 21, 2018
Dec. 31, 2016
Business Acquisition [Line Items]              
Area of land | ft²       300,000      
Members Kind Therapeutics USA Inc [Member]              
Business Acquisition [Line Items]              
Equity onwership percentage             30.00%
The Harvest Foundation LLC [Member]              
Business Acquisition [Line Items]              
Percentage of interests acquired in business acquisition   100.00%          
The Harvest Foundation LLC [Member] | Two Owners [Member]              
Business Acquisition [Line Items]              
Sale of stock, shares | shares   1,000,000          
Sale of stock, value | $   $ 1.2          
Warrants to purchase shares | shares   400,000          
Kind Therapeutics USA Inc. [Member]              
Business Acquisition [Line Items]              
Percentage of interests acquired in business acquisition           100.00%  
Equity onwership percentage             70.00%
Payment for business acquisition | $     $ 6.3        
Stock issued during period, shares, acquisitions | shares     2,500,000        
Lessor, operating lease, term of contract     20 years        
Area of land | ft²     180,000        
Kind Therapeutics USA Inc. [Member] | Anne Arundel County, MD [Member]              
Business Acquisition [Line Items]              
Area of land | ft²         9,000    
Meditaurus LLC [Member]              
Business Acquisition [Line Items]              
Equity onwership percentage 70.00%            
Payment for business acquisition | $ $ 2.8            
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Fair Value Method       The Company currently sells CBD products developed by MediTaurus under its Florance™ brand, and expects to acquire the remaining 30% of MediTaurus in 2021.